Find Academic Supervisors

Jesper Bøje AndersenView profile

Professor

• Immunogenomics
• Metabolism
• Epigenomic remodeling
• +7 more

Professor Jesper Bøje Andersen is a Professor in Translational Hepatology at the University of Copenhagen, based at the Biotech Research and Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences. He leads the Andersen Group, which focuses on utilizing genome-wide approaches to model disease causality and develop diagnostic, prognostic, and therapeutic strategies for hepatobiliary cancers. Education: PhD in Translational Genomics and Epigenomics from Aarhus University, Denmark (2006) Joint research fellowship at University of Maryland, Department of Medicine, Marlene and Stewart Greenebaum Cancer Center, Baltimore, USA (2003-2007) Professor Andersen's research centers on three main themes: Immunogenomics, metabolism, and epigenomic remodeling in the context of hepatobiliary cancers. His work aims to significantly guide novel treatment modalities and impact clinical practice to improve patient outcomes. The Andersen Group employs cutting-edge technologies including single-cell genomics, tumor heterogeneity analysis, and cross-species integrative omics approaches to understand liver and bile duct cancers at a molecular level. Analysis of Professor Andersen's recent publications reveals a strong focus on cholangiocarcinoma and hepatocellular carcinoma, with research spanning from basic molecular mechanisms to clinical applications. His work increasingly integrates genomic, epigenomic, and immunological approaches to develop precision medicine strategies for liver cancers. Notably, his team has been advancing understanding of tumor heterogeneity, molecular subtypes, and potential therapeutic targets in biliary tract cancers. Scientific Awards: Danish Cancer Society Research Scholarship (2002) AFAR Junior Investigator Award (2007) ISICR Young Investigator Award (2007) Danish Medical Research Council Award (2008) EASL Young Investigator Award (2008) ILCA Investigator Award (2010) Danish Cancer Society "Knæk Cancer" Talented Young Investigator (2014) Novo Nordisk Foundation Hallas-Møller Fellowship (2015) Novo Nordisk Foundation Research Leader Program (2022) Professor Andersen is an active mentor and advisor, having founded and directed BRIC's Postdoc Career Program. He has secured numerous competitive grants from Danish and European funding agencies, including the European Association for the Study of the Liver (EASL) Sheila Sherlock fellowship and multiple Marie Sklodowska-Curie postdoctoral fellowships. His research has been supported by prestigious organizations including the Independent Research Fund Denmark, Danish Cancer Society, and Novo Nordisk Foundation. The Andersen Group operates within the Biotech Research and Innovation Centre (BRIC) at the University of Copenhagen. Professor Andersen has co-founded several international collaborations including the European Network for the Study of Cholangiocarcinoma (ENSCCA), Global Cholangiocarcinoma Alliance, and Precision-BTC network. He serves as an active participant in the Cholangiocarcinoma Foundation USA and member of the International Cholangiocarcinoma Research Network, demonstrating his leadership in creating global research networks focused on rare liver cancers.

• Risk factors for glaucoma
• Ocular health
• Dry eye disease
• +3 more

Jens Rovelt is a Guest Researcher in the Department of Drug Design and Pharmacology at the University of Copenhagen, concurrently serving as Senior Development Scientist at Astellas Pharma Inc. His academic background includes an MSc in Bioinformatics and a PhD. His primary research focuses on risk factors for glaucoma and ocular health, extending to dry eye disease, ocular surface disorders, and retinal vessel morphology. He employs large-scale epidemiological approaches, notably through the FOREVER cohort involving over 57,000 subjects, to investigate systemic-ocular disease relationships including associations with atopic dermatitis and diabetes. Rovelt's recent publications (2024-2025) demonstrate a consistent emphasis on population-based ophthalmic research, with key themes including glaucoma risk stratification, dry eye symptomatology linked to artificial tear formulations, and vascular/metabolic factors influencing eye health. His work frequently involves multi-institutional collaborations and leverages datasets exceeding 60,000 participants for robust statistical analysis.

Freddy LippertView profile

Lecturer

• Emergency Medicine
• Prehospital Care
• Cardiac Arrest Resuscitation
• +5 more

Freddy Lippert serves as an External Lecturer in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with a specific focus on Emergency Medicine. He concurrently holds the position of International Chief Medical Officer at Falck, a global emergency services provider, a role he has held since October 1, 2022. His work bridges academic research with practical emergency medical services implementation on an international scale. University: University of Copenhagen School: Faculty of Health and Medical Sciences Department: Emergency Medicine External Position: International Chief Medical Officer at Falck (since 2022) Dr. Lippert's research focuses on critical aspects of emergency medical systems worldwide, particularly examining cardiac arrest resuscitation practices, ambulance response effectiveness, and the implementation of life-saving skills training across different healthcare systems. His work frequently employs large-scale registry data and international collaborations to identify best practices and areas for improvement in prehospital care. A growing emphasis in his recent work involves the application of artificial intelligence to enhance emergency care systems, especially in resource-limited settings. His publication record demonstrates consistent productivity with 266 research outputs including 229 journal articles, 8 reviews, 7 editorials, and 6 book chapters. His 2024-2025 publications reveal a strong focus on global emergency care systems, with particular attention to cardiac arrest outcomes, ambulance response metrics, and the integration of technology in emergency medical services. Dr. Lippert actively collaborates with researchers across numerous countries, as evidenced by his international co-authorship patterns. His work with The Global Prehospital Resuscitation Network highlights his commitment to improving emergency care standards worldwide. While specific grant information isn't detailed in the available text, his extensive international collaborations suggest significant research funding support for his work in global emergency medicine. His research has gained attention across academic and professional platforms, with multiple publications shared on social media by X (Twitter) users, referenced on Bluesky, and covered by news outlets. His work maintains a strong readership on academic platforms like Mendeley, indicating its relevance to emergency medicine professionals and researchers globally.

• Glaucoma
• Retinal Vessel Morphology
• Automated Image Analysis
• +3 more

Josefine Freiberg serves as a Guest Researcher in the Department of Drug Design and Pharmacology within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her work centers on translational clinical pharmacology with a specialized focus on glaucoma pathogenesis and diagnostic innovation through advanced retinal imaging techniques. Education: MD, University of Copenhagen Research Focus: Dr. Freiberg investigates retinal vessel morphology as a biomarker for glaucoma progression, develops automated image analysis protocols for retinal scans, and identifies early biomarkers for primary open-angle glaucoma. Her research leverages the large-scale FOREVER cohort (57,464 subjects) to explore ocular-systemic disease links, particularly between atopic dermatitis and ocular surface disease. She actively examines pharmaceutical safety profiles of artificial tears and preservatives in ophthalmic formulations. Publication Trends: Recent work (2024-2025) demonstrates strong emphasis on glaucoma outcome measures, nongenetic risk factors, and ocular surface disease epidemiology. Her systematic reviews establish new methodological standards for clinical trials, while FOREVER cohort analyses reveal critical associations between vascular parameters and glaucoma progression. Collaborative publications span ophthalmology, dermatology, and pharmaceutical science journals. Scientific Recognition: Best Young Investigator contribution (Glaucoma) - October 2, 2021 Dr. Freiberg contributes significantly to the FOREVER consortium's mission of optimizing predictive eye exam reliability in community optometry settings. Her translational approach bridges clinical observation with pharmaceutical science, particularly regarding preservative toxicity in ocular therapeutics.

• Pediatric Cardiology
• Congenital Heart Disease
• Fetal Medicine
• +2 more

James Gaynor Gaynor serves as an Affiliate Professor within the Department of Clinical Medicine at the University of Copenhagen, maintaining a dual institutional affiliation with the Children's Hospital of Philadelphia (CHOP) as indicated by his professional email address. His academic role bridges clinical practice and research in pediatric cardiovascular medicine. Research interests prominently feature pediatric cardiology , congenital heart defects , and fetal diagnostics , with expanding focus on neurodevelopmental outcomes in cardiac patients and machine learning applications for clinical prediction. His work integrates advanced imaging techniques, longitudinal patient studies, and computational modeling to address critical gaps in congenital heart disease management. Recent publications (2022-2024) demonstrate consistent output in high-impact journals, revealing three dominant research trajectories: 1) Fetal MRI applications for congenital heart defect diagnosis, 2) Long-term neurocognitive and academic impacts of cardiac conditions, and 3) Data-driven predictive modeling for clinical deterioration. These studies frequently involve international collaborations across European and North American institutions. No scientific awards were documented in the source material. Information regarding student supervision, grant funding, laboratory infrastructure, or research teams was not provided in the extracted content.

Hermina JakupovicView profile

Research Fellow

• Genetic Epidemiology
• Type 2 Diabetes Research
• Obesity Genetics
• +3 more

Hermina Jakupovic is a Postdoctoral Researcher at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Public Health, specifically within the Section for Health Data Science and AI. Her primary affiliation spans genetic epidemiology and public health data science, with a focus on type 2 diabetes and obesity research. Position: Postdoc, Section for Health Data Science and AI Institution: University of Copenhagen Department: Public Health Contact: hermina.jakupovic@sund.ku.dk | ORCID: 0000-0001-9667-9406 Her research centers on genetic and environmental interactions in metabolic diseases, particularly examining how lifestyle factors and genetic predisposition jointly influence type 2 diabetes risk. Key investigations include fetal insulin resistance effects on birth weight, leptin regulation in early adiposity, and dietary fat interactions with genetic risk. Her work frequently employs large-scale genomic datasets and multi-ancestry study designs to uncover gene-environment interactions. Analysis of her 11 publications (2019-2022) reveals dominant themes in genetic epidemiology of metabolic disorders , with high-impact contributions to diabetes research. Notable trends include the 2020 Diabetologia paper (168 Scopus citations) demonstrating obesity and lifestyle factors increase diabetes risk independent of genetic predisposition, and multi-ancestry lipid studies identifying physical activity-interacting loci. Her methodological approach integrates genomic analysis with public health data science frameworks. While no formal scientific awards are documented in the provided materials, her research has garnered significant attention with publications referenced in patents, covered by 34+ news outlets, and shared by 108+ X users. Her 2020 Diabetes paper alone attracted 395 Mendeley readers. Dr. Jakupovic actively collaborates within international consortia including the Leptin Exomechip Collaboration and LifeLines Cohort Study. Her work involves extensive data analysis from population cohorts, though specific grant funding or lab leadership details are not provided in the source materials. Current research directions appear focused on refining genetic risk prediction models incorporating lifestyle variables.

• Head and Neck Oncology
• Oropharyngeal Cancer Research
• HPV-Related Cancers
• +3 more

Jacob Høygaard Rasmussen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on head and neck oncology, particularly HPV-mediated oropharyngeal cancers, with extensive work on cancer staging, prognosis, and diagnostic imaging techniques. Dr. Rasmussen's research interests center on the epidemiology, diagnosis, and treatment of head and neck cancers, with particular emphasis on HPV-related oropharyngeal carcinoma. His work explores the prognostic implications of various biomarkers including p16 and HPV status, cancer staging systems, and the application of advanced imaging techniques like 3D ultrasound and MRI for surgical planning. His research bridges clinical practice with epidemiological analysis, examining trends in cancer incidence and outcomes across different populations. His publication record demonstrates a strong focus on head and neck cancer research with particular attention to HPV-related oropharyngeal cancers. His recent work examines the accuracy of radiologic imaging for assessing cancer spread, risk stratification models for clinical trials, international comparisons of cancer outcomes, and the epidemiological trends of oropharyngeal cancer in high HPV-prevalence regions. His research frequently involves large-scale, multinational collaborations such as the Head and Neck Cancer International Group (HNCIG). Dr. Rasmussen's work has garnered significant attention in the scientific community, with multiple publications receiving substantial citations and media coverage. His 2023 Lancet Oncology paper on p16 and HPV discordance in oropharyngeal cancer has been particularly influential, with over 180 citations, mentioned in news outlets, social media, Wikipedia pages, and clinical guidelines. His research activities include participation in clinical diagnostic accuracy studies examining 3D ultrasound and MRI for assessing resection margins during tongue cancer surgery, as well as investigations into the clinical implications of genetic intratumor heterogeneity for targeted therapy in head and neck cancer. His collaborative work spans multiple institutions across Denmark and internationally, reflecting the global significance of his research in the field of head and neck oncology.

• Survival analyses
• Statistical genetics
• Time-to-event data
• +4 more

Thomas Scheike is a Professor in the Department of Public Health, Section of Biostatistics at the University of Copenhagen. He holds a Dr. Scient degree from 2002 and a PhD from 1993, with an ORCID identifier of 0000-0002-2148-4740. His research expertise includes: Survival analyses and time-to-event data methodology Statistical genetics applied to twin and family studies Competing risks data analysis Dependence structures in multivariate event history data Professor Scheike has developed significant statistical software for R, including the Timereg package for survival analysis and the Mets package for multivariate polygenetic modeling. He teaches courses primarily for medical PhD students in survival analysis, statistical software applications, medical statistics, and methods for twin and family studies, as well as specialized courses for statistics PhD students. His recent publications (2025) demonstrate the broad application of his biostatistical methods across cardiology, psychiatry, gastroenterology, neurology, and environmental health fields. These works often involve large-scale cohort studies and twin research designs, showcasing his methodological innovations in analyzing complex longitudinal data. Professor Scheike maintains an active research profile with substantial contributions to biostatistical methodology, particularly in the analysis of survival data with applications across diverse medical disciplines.

• Macrophage phenotypes
• Atherogenesis
• Uremia
• +5 more

Line Bisgaard serves as a Teaching Assistant Professor and Guest Researcher in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. Her academic work spans both teaching responsibilities and active research in cardiovascular and kidney disease mechanisms, with particular focus on macrophage phenotypes in atherosclerotic plaques and the relationship between kidney disease and accelerated atherosclerosis. M.Sc., Molecular Biomedicine, University of Copenhagen (2010) Dr. Bisgaard's research program centers on two primary areas: investigating macrophage phenotype composition in atherosclerotic plaques compared to in vitro models, and examining mechanisms underlying acceleration of atherosclerosis in relation to kidney disease. She specifically explores whether development of insulin resistance explains the accelerated atherogenesis observed in kidney disease patients. Her work bridges cardiovascular biology and nephrology, with strong emphasis on molecular mechanisms and biomarker discovery. Analysis of her 15 most recent publications (2021-2025) reveals a consistent research trajectory focused on the intersection of cardiovascular disease and kidney pathology. The publications demonstrate expertise in metabolomics, biomarker identification, and molecular pathways linking kidney dysfunction to cardiovascular complications. Key recurring themes include apolipoprotein M research, macrophage biology in atherosclerosis, and metabolic signatures of disease progression. Dr. Bisgaard maintains active research collaborations across multiple institutions, as evidenced by her co-authorship on publications with researchers from diverse specialties including cardiology, nephrology, and molecular biology. Her work appears in high-impact journals such as Arteriosclerosis, Thrombosis, and Vascular Biology , Clinical Nutrition , and Atherosclerosis . Her laboratory work is conducted within the Physiology of circulation, kidney and lung research group at the Department of Biomedical Sciences, University of Copenhagen, with additional connections to the Diabetes Complications Biology department at Novo Nordisk where she conducts part of her PhD research.

• Diabetes
• General Practice
• Public Health
• +3 more

Lars J Hansen serves as an External Lecturer in the Department of Public Health's Section of General Practice at the University of Copenhagen, with contact details including phone +4548301188 and email l.j.hansen@sund.ku.dk. His academic role bridges teaching and diabetes-focused research within primary care settings. His research portfolio emphasizes Type 2 Diabetes management , leveraging urinary biomarkers for cancer/mortality prediction and developing patient-centered care models to prevent complications. Key methodologies include longitudinal cohort studies (e.g., the 19-year DCGP project) and participatory research to enhance academic capacity in general practice, reflecting interdisciplinary work spanning clinical medicine, public health, and medical education. Analysis of his 2011-2015 publications reveals consistent themes: oxidative stress biomarkers in diabetes outcomes, structured treatment personalization, and evidence-based guideline development. His work demonstrates real-world impact through citations in policy documents and media coverage, though it remains anchored in epidemiological and clinical primary care contexts. No scientific awards were documented in the source material. Details regarding student mentorship or research grants were not provided, indicating these aspects fall outside the current public profile. Information about dedicated laboratories or research teams was absent from the available data.

• Population Genetics
• Evolutionary Biology
• Statistical Genetics
• +4 more

Jonas Meisner serves as an Assistant Professor in the Rasmussen Group at the Faculty of Health and Medical Sciences, University of Copenhagen. His research program bridges population genetics, evolutionary biology, and statistical methodology development, with significant contributions to understanding genetic variation in both human and wildlife populations. Meisner's research interests center on population structure analysis , ancestry estimation methods , polygenic prediction techniques , and evolutionary history reconstruction . His work applies sophisticated statistical approaches to genomic datasets from diverse populations including Greenlandic Inuit communities and wildlife species such as giraffes and wildebeest. This research has important implications for understanding human adaptation, disease susceptibility patterns, and conservation strategies for endangered species. His publication record demonstrates a clear trajectory toward interdisciplinary research that integrates population genetics with evolutionary biology and medical genomics. Meisner frequently employs large-scale genomic analyses of both contemporary and ancient DNA samples, with particular emphasis on Arctic-adapted populations and wildlife conservation genetics. His methodological innovations in ancestry estimation and haplotype-based analysis have been featured in premier scientific journals including Nature, Cell, and Nature Genetics. Meisner is affiliated with the Rasmussen Group, a research team focused on advancing population genetics methodologies and applying them to significant biological and medical questions. The group's collaborative work spans human medical genetics, wildlife conservation genetics, and computational method development in statistical genetics.

• Atmospheric Science
• Environmental Radioactivity
• Risk Assessment
• +2 more

Jens Sørensen is a Lecturer in the Department of Cellular and Molecular Medicine at the University of Copenhagen, affiliated with the ICMM Teaching unit. His departmental role suggests involvement in biomedical education, though his research publications focus on atmospheric science and environmental risk modeling. His research interests include atmospheric dispersion, radionuclide transport, and environmental risk assessment. Publications demonstrate expertise in predictive modeling for industrial pollutants and nuclear contaminants, emphasizing emergency response frameworks and climate impact analysis.

• Neuroscience
• Psychiatry
• Mood Disorders
• +4 more

Julian Macoveanu serves as a Guest Researcher at the Department of Psychology within the Faculty of Social Sciences at the University of Copenhagen. His research program focuses on the neural mechanisms underlying mood disorders, particularly examining brain structure-function relationships in bipolar disorder and major depressive disorder using advanced neuroimaging techniques. Dr. Macoveanu's research interests span clinical neuroscience with emphasis on: Neural correlates of cognitive impairment in mood disorders Brain structural and functional changes associated with psychiatric conditions Neural predictors of treatment response to interventions like electroconvulsive therapy Emotion regulation processes in bipolar disorder Longitudinal brain changes in psychiatric populations and their relatives His recent publication record demonstrates a cohesive research trajectory investigating how specific brain regions (particularly amygdala and hippocampal structures) relate to clinical symptoms and treatment outcomes. Dr. Macoveanu employs sophisticated fMRI methodologies to examine both structural and functional neural characteristics across multiple patient populations. Dr. Macoveanu maintains an active research profile with multiple publications appearing in high-impact psychiatric journals including Journal of Affective Disorders, Bipolar Disorders, and Acta Psychiatrica Scandinavica. His work frequently appears with significant social media engagement and academic readership as indicated by X (Twitter) mentions and Mendeley reader counts. His research collaborations extend across multiple departments at the University of Copenhagen, particularly working with clinical psychiatry researchers to bridge neuroimaging findings with clinical applications. Dr. Macoveanu's work contributes to the growing understanding of neural biomarkers that could potentially inform more personalized treatment approaches for mood disorders.

Johanne Marie JustesenView profile

Assistant Professor

• Genetics
• Metabolic Diseases
• Diabetes Research
• +5 more

Johanne Marie Justesen serves as an Assistant Professor at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research is prominently featured in high-impact journals across multiple disciplines including genetics, metabolic diseases, and cardiovascular biology. Her research interests focus on the genetic underpinnings of metabolic disorders, particularly fatty liver disease, diabetes, and cardiovascular conditions. Dr. Justesen employs genomic and molecular approaches to investigate how genetic variants influence disease mechanisms and metabolic pathways. Her work bridges basic science with clinical applications, exploring how genetic risk factors interact with lifestyle elements like physical activity and diet. Analysis of Dr. Justesen's publication record reveals a strong focus on polygenic risk scores, gene variant effects on metabolic parameters, and the molecular mechanisms underlying metabolic dysfunction. Her research spans from basic genomic analysis to translational studies with potential clinical applications, particularly in diabetes and cardiovascular disease management. Dr. Justesen is affiliated with the Grarup Group at CBMR, which focuses on the genetic architecture of metabolic diseases. Her collaborative network includes researchers across multiple institutions, as evidenced by her extensive co-authorship on publications involving international teams. The significant media coverage of her work (picked up by over 40 news outlets for some publications) indicates the relevance and impact of her research in the scientific community.

Jessica Xin HjaltelinView profile

Associate Professor

• Health Data Science
• Artificial Intelligence in Medicine
• Cancer Detection
• +4 more

Jessica Xin Hjaltelin is an Associate Professor in the Department of Public Health at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Health Data Science and AI. She also serves as a Guest Researcher at the Novo Nordisk Foundation Center for Protein Research in the Brunak Group. Her research focuses on applying artificial intelligence and data science techniques to healthcare data, particularly for cancer detection and disease trajectory analysis. Key areas include: AI-aided mining of medical records for cancer screening Disease progression modeling using population-wide health data Pancreatic cancer risk prediction and early detection Multi-cancer risk stratification using national health registries Visualization of disease trajectories from electronic health records Dr. Hjaltelin's recent work demonstrates significant impact, with publications in high-impact journals including Nature Medicine, The Lancet Oncology, and The Lancet Digital Health. Her research on pancreatic cancer has received substantial attention, with one paper picked up by 106 news outlets and referenced in Wikipedia. She collaborates extensively with researchers across multiple institutions on projects bridging data science and clinical medicine. Among her notable scientific contributions: Development of deep learning algorithms for predicting pancreatic cancer risk Creation of multi-cancer risk stratification models using national health data Analysis of pancreatic cancer symptom trajectories from registry data Research on biomarkers for treatment response in metastatic pancreatic cancer Dr. Hjaltelin maintains active collaborations with clinical researchers and participates in significant oncology studies, including the CheckPAC clinical trial investigating immunotherapy combinations for pancreatic cancer.